Patients and their treating oncologists are faced with many challenges today, including rising drug prices and the opioid crisis, as well as clinical pathway optimization and algorithms to furthering community oncology engagement in clinical research.
To discuss it all, I sit down with Clifford Hudis, MD, FACP, FASCO, chief executive officer of ASCO, at the recent ASCO annual meeting (2019 meeting in Chicago). In this one-on-one interview, Dr Hudis shares his views and describes how ASCO is working to optimize care delivery for patients amid these challenges in oncology care.
What an honor for me to interview the CEO of the largest oncology society in the world (ASCO); must listen.
This podcast is produced by the Journal of Clinical Pathways.
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
